| Literature DB >> 19889065 |
Grant D Stewart1, James A Ross, Duncan B McLaren, Christopher C Parker, Fouad K Habib, Antony C P Riddick.
Abstract
Research into the hypoxic tumour microenvironment is accelerating and the reversal of hypoxia is increasingly being suggested as a mechanism for improving cancer treatment. Recent studies have suggested that hypoxia is also a feature in prostate cancer and is associated with a poor prognosis. Hypoxia has been shown to cause radio-resistance and hence hamper one of the major treatments for prostate cancer. However, unlike other solid tumours, such as cervical and head-and-neck cancer, there are inconsistencies and unanswered questions about the relevance of hypoxia in prostate cancer. This review outlines the role of low-oxygen conditions in prostate cancer and the areas where further studies are required.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19889065 DOI: 10.1111/j.1464-410X.2009.08921.x
Source DB: PubMed Journal: BJU Int ISSN: 1464-4096 Impact factor: 5.588